Computational Medicine And Drug Discovery Software Market: By Tools 2023 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Computational medicine and drug discovery software market
Computational Medicine And Drug Discovery Software Market: By Tools (Software, Databases and Others); By Application (Drug Discovery and Development, Disease Modeling, Medical Imaging and Others) & By Geography - Forecast (2018-2023)
Report Code : HCR 0016
Updated Date: 10 June, 2018  
16

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Computational Medicine and Drug Discovery Software Market Overview 
2. Executive Summary 
3. Computational Medicine and Drug Discovery Software Market Landscape 
   3.1. Market Share Analysis 
   3.2. Comparative Analysis 
      3.2.1. Product Benchmarking 
      3.2.2. End User Profiling 
4. Computational Medicine and Drug Discovery Software - Market Forces 
   4.1. Market Drivers 
      4.1.1. The Rise of Bioinformatics in Drug Discovery 
      4.1.2. Three Dimensional Drug Discovery Methodology 
      4.1.3. Increase in Late Stage Drug Discovery Failure 
   4.2. Market Challenges 
      4.2.1. Lack of Skilled Professionals 
      4.2.2. Complexity Associated With Analysis of Data 
   4.3. Market Constraints 
      4.3.1. Stringent Regulatory Approval for Novel Drugs 
   4.4. Attractiveness of the Industry 
      4.4.1. Power of Suppliers 
      4.4.2. Power of Customers 
      4.4.3. Threat of New Entrants 
      4.4.4. Threat of Substitution 
      4.4.5. Degree of Competition 
5. Computational Medicine and Drug Discovery Software Market – Strategic Analysis 
   5.1. Opportunity Analysis 
      5.1.1. Cloud and Mobile Platforms Provides Investment Opportunities 
      5.1.2. Enterprise Level Computational software Holds Growth Prospects 
   5.2. Value Chain Analysis 
   5.3. Product/Industry Life Cycle Analysis 
   5.4. Suppliers & Distributors 
   5.5. Pricing Analysis 
6. Computational Medicine and Drug Discovery Software Market – By Tools 
   6.1. Introduction 
   6.2. Database 
   6.3. Software 
   6.4. Others 
7. Computational Medicine and Drug Discovery Software Market – By Application 
   7.1. Introduction 
   7.2. Computational Physiological Medicine 
   7.3. Drug Discovery and Development 
   7.4. Medical Imaging 
   7.5. Disease Modeling 
   7.6. Predictive Analysis of Drug Targets 
   7.7. Cellular Simulation 
   7.8. Simulation Software 
   7.9. Genomics
   7.10. Proteomics
   7.11. Molecular Biology
   7.12. Gene expression analysis
   7.13. Others
8. Computational Medicine and Drug Discovery software- Market Geographic Analysis
   8.1. North America 
      8.1.1. U.S. 
      8.1.2. Canada 
      8.1.3. Mexico 
      8.1.4. Rest of North America
   8.2. South America 
      8.2.1. Brazil 
      8.2.2. Venezuela
      8.2.3. Argentina
      8.2.4. Ecuador
      8.2.5. Peru
      8.2.6. Colombia 
      8.2.7. Costa Rica
      8.2.8. Rest of South America
   8.3. Europe 
      8.3.1. U.K 
      8.3.2. Germany 
      8.3.3. Italy 
      8.3.4. France
      8.3.5. Netherlands
      8.3.6. Belgium
      8.3.7. Spain
      8.3.8. Denmark
      8.3.9. Rest of Europe
   8.4. APAC
      8.4.1. China 
      8.4.2. Australia 
      8.4.3. South Korea
      8.4.4. India
      8.4.5. Taiwan
      8.4.6. Malaysia
      8.4.7. Hong Kong 
      8.4.8. Rest of APAC
   8.5. Middle East& Africa 
      8.5.1. Israel
      8.5.2. South Africa
      8.5.3. Saudi Arabia
   8.6. Rest of Middle East and Africa
9. Market Entropy
   9.1. New Product Launches
   9.2. M&As, Collaborations, JVs and Partnerships
10. Company Profiles
   10.1. Compugen Ltd.
   10.2. Certara
   10.3. L.P.
   10.4. Dassault Systemes
   10.5. Schrödinger LLC
   10.6. Genedata AG
   10.7. Company 7
   10.8. Company 8
   10.9. Company 9
   10.10. Company 10
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
   11.1. Abbreviations 
   11.2. Sources 
   11.3. Research Methodology
   11.4. Expert Insights
The computational medicine and drug discovery market is poised to grow at a CAGR of 5.1% during 2017-23 and was valued at $5.88 billion in 2017. The growth will be driven by advancement in bioinformatics and various drug discoveries due to the increase in number of diseases. Bioinformatics has made it possible to integrate and analyze large datasets in developing better treatment for chronic diseases such as cancer and other genetic disorders. Computational physiology medicine attained a revenue of $897 million in 2017. North American region dominates the computational medicine and drug discovery market and generated a revenue of $2,882.9 million and is estimated to rise with a CAGR of 3.7% during 2017-2023.

What is Computational Medicine and Drug Discovery?
Computational Medicine involves a combination of mathematics, engineering and computer science. It is an emerging field which is devoted to develop for understanding the mechanisms, diagnosis and treatment of human disease. The main aim of this field is to develop computational models for molecular biology, physiology, and anatomy of disease, and apply these models to improve patient care. 

Drug discovery is process through which new medicines have been discovered. It includes various disciples such as biology, chemistry and pharmacology. Drug discovery is a process which involves the identification of drug target, synthesis, characterization, screening, and assays for therapeutic efficacy.

What are the applications of Computational Medicine and Drug Discovery Software?
Computational medicine and drug discovery software play an important role in the development drugs for various diseases such as cancer and other genetic disorders. Computational medicine also helps to detect the fault in the genes and thus helps to predict the cause of the disease. It is widely used disease monitoring and medical imaging and personalized medicine. Computational medicine and drug discovery software are used to understand the protein – protein interactions as well as protein – ligand interactions which makes it easier to find the drug target.

Computational Medicine and Drug Discovery Software Market

Market Research and Market Trends of Computational Medicine and Drug Discovery Software:
  • Nvidia is strategically shifting its focus from computer hardware industry to healthcare industry. It has partnered with companies like GE, Mayo Clinic and Nuance healthcare to define the workflow. They have been developing a computational software which would aid to virtualize all the hospital work and all the different instruments. These computational approaches hold a promise to improve the image quality and help the doctor to predict the diseases which would otherwise take time. They are also focused on developing deep learning in genomics and drug discovery and make way towards personalized medicine. 
  • Fujitsu Laboratories Ltd. and Fujitsu Limited announced the development of molecular simulation technology for drug discovery. This development can accurately estimate binding affinity between the target protein and the chemical substance which helps to predict the drug’s efficiency. This technique also estimates the degree of torsion in a chemical substance as well as the impact of neighboring atoms and thus will help in the development of new targeted therapies.
  • Researchers from KAIST, Korea developed DeepDDI, a computational framework that accurately predicts and generates 86 types of drug-drug and drug-food interactions. These interactions can help us to predict unexpected pharmacological effects such as adverse drug events (ADEs) and other unknown mechanisms. However, the current prediction methods do not provide detailed drug interactions.
  • In February 2018, Roche acquired oncology tech company Flatiron Health in order to implement the use of artificial intelligence as another tool to facilitate drug discovery and help the company progress. This acquisition with Flatrion Health provided the required technology and data analytics needed for Roche as well as oncology research and development across the industry. 

Who are the Major Players in Computational Medicine and Drug Discovery Software market?
The companies referred in the market research report are Compugen Ltd., Certara, L.P., Dassault Systemes, Schrödinger LLC, Genedata AG and several others.

What is our report scope?
The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2018-2023.

All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report
  • Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
  • Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
  • Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.
  • Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes. 
  • Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years. 
  • Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market. 
List of Tables:

Table 1. Computational Medicine and Drug Discovery Software Market: Top Companies with Rankings, 2015   
Table 2. Regional Markets and Their Life Cycle Stages   
Table 3. Databases for Genome and Proteome Annotation   
Table 4. Softwares for Genome Annotation   
Table 5. Drug Discovery & Development Process   
Table 6. Global Computational Medicine and Drug Discovery Software Market, by Region, 2014-2020 ($Million)   
Table 7. Americas: Computational Medicine and Drug Discovery Software Market, by Tools, 2014-2020 ($Million)   
Table 8. Americas: Computational Medicine and Drug Discovery Software Market, by Application, 2014-2020 ($Million)   
Table 9. Americas: Computational Medicine and Drug Discovery Software Market, by Country, 2014-2020 ($Million)   
Table 10. Europe: Computational Medicine and Drug Discovery Software Market, by Tools, 2014-2020 ($Million)   
Table 11. Europe: Computational Medicine and Drug Discovery Software Market, by Application, 2014-2020 ($Million)   
Table 12. Europe: Computational Medicine and Drug Discovery Software Market, by Country, 2014-2020 ($Million)   
Table 13. APAC: Computational Medicine and Drug Discovery Software Market, by Tools, 2014-2020 ($Million)   
Table 14. APAC: Computational Medicine and Drug Discovery Software Market, by Application, 2014-2020 ($Million)   
Table 15. APAC: Computational Medicine and Drug Discovery Software Market, by Country, 2014-2020 ($Million)   
Table 16. Computational Medicine and Drug Discovery Software Market: Product Expansion   
Table 17. Computational Medicine and Drug Discovery Software Market: Partnerships/Collaboration   
Table 18. Biognos AB: Products and Applications   
Table 19. Chemical Computing Group Inc: Products and Applications   
Table 20. Compugen Ltd. : Products and Applications   
Table 21. Dassault Systèmes: Computational Medicine and Drug Discovery Software Products and Applications   


List of Figures:

Figure 1. Computational Medicine and Drug Discovery Software, Classification   
Figure 2. Computational Medicine and Drug Discovery Software, by Tools   
Figure 3. Computational Medicine and Drug Discovery Software, by Application   
Figure 4. Computational Medicine and Drug Discovery Software, by Geography   
Figure 5. Global Computational Medicine and Drug Discovery Market, 2014-2020 ($Million)   
Figure 6. Computational Medicine and Drug Discovery Market Share, by Geography, 2014 (%)   
Figure 7. Computational Medicine and Drug Discovery Software Market: Value Chain   
Figure 8. Global Computational Medicine and Drug Discovery Market Revenue, by Region, 2014 & 2020 ($Million)   
Figure 9. Current and Future Focus Parameters   
Figure 10. Global CMDD Database Market Revenue, 2014-2020 ($Million)   
Figure 11. Global CMDD Software Market Revenue, 2014-2020 ($Million)   
Figure 12. Global CMDD Others Market Revenue, 2014-2020 ($Million)   
Figure 13. Global Computational Medicine and Drug Discovery Software Market, by Application, 2014-2020 ($Million)   
Figure 14. Global CMDDS Computational Physiological Medicine Market, 2014-2020 ($Million)   
Figure 15. Global CMDDS Drug Discovery and Development Market, 2014-2020 ($Million)   
Figure 16. NHS Imaging Activities in England, 2014 (Units)    
Figure 17. Global CMDDS Medical Imaging Market, 2014-2020 ($Million)   
Figure 18. Global CMDDS Disease Modeling Market, 2014-2020 ($Million)   
Figure 19. Global CMDDS Predictive Analysis of Drug Target Market, 2014-2020 ($Million)   
Figure 20. Global CMDDS Cellular Simulation Market, 2014-2020 ($Million)   
Figure 21. Global CMDDS Simulation Software Market, 2014-2020 ($Million)   
Figure 22. U.S.: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 23. Canadian Pharmaceutical Industry: R&D Expenditure, 2007-2013 ($Billion)   
Figure 24. Canada: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 25. Rest of Americas: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 26. U.K.: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 27. Germany: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 28. The Netherlands: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 29. Norway: Total Spending on Healthcare as a Percentage of GDP at Market Prices, 1970-2014 (%)   
Figure 30. Norway: Computational Medicine and Drug Discovery Software Market, 2014-2020 ($Million)   
Figure 31. Italy: Total Spending on Healthcare as a Percentage of GDP at Market Prices, 1970-2014 (%)   
Figure 32. Italy: Computational Medicine and Drug Discovery Software Market, 2014-2020 ($Million)   
Figure 33. Rest of Europe Computational Medicine and Drug Discovery Software Market, 2014-2020 ($Million)   
Figure 34. Total Health Expenditure in APAC Countries, 2014 (% of GDP)   
Figure 35. China: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 36. Japan: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 37. Korea: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 38. Australia: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 39. Rest of APAC: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 40. Healthcare Spending in Middle East and Africa, 2008-2014 ($Billion)   
Figure 41. Row: Computational Medicine and Drug Discovery Software Market, by Tools, 2014-2020 ($Million)   
Figure 42. Row: Computational Medicine and Drug Discovery Software Market, by Application, 2014-2020 ($Million)   
Figure 43. Total Developments, by Type of Development, 2011-2015   
Figure 44. Financial Performance, 2010-2014, ($Millionn)   
Figure 45. Compugen Ltd. Total Revenue from Sales to Customers, by Region, 2014 (%)   
Figure 46. Dassault Systemes: Financial Performance, 2012-2014, ($Billion)   
Figure 47. Dassault Systemes: Total Revenue, by Region, 2014, (%)   


Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll